Cargando…
Antigen-based diagnosis of Schistosoma infection in travellers: a prospective study
BACKGROUND: Travellers infected with Schistosoma spp. might be pauci- or even asymptomatic on first presentation. Therefore, schistosomiasis may remain undiagnosed in this population. Active infection, as evidenced by the presence of the tissue-dwelling worm, can be demonstrated via the detection of...
Autores principales: | Casacuberta-Partal, Miriam, Janse, Jacqueline J, van Schuijlenburg, Roos, de Vries, Jutte J C, Erkens, Marianne A A, Suijk, Kitty, van Aalst, Mariëlle, Maas, Jaap J, Grobusch, Martin P, van Genderen, Perry J J, de Dood, Claudia, Corstjens, Paul L A M, van Dam, Govert J, van Lieshout, Lisette, Roestenberg, Meta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359925/ https://www.ncbi.nlm.nih.gov/pubmed/32307517 http://dx.doi.org/10.1093/jtm/taaa055 |
Ejemplares similares
-
Excretion patterns of Schistosoma mansoni antigens CCA and CAA by adult male and female worms, using a mouse model and ex vivo parasite cultures
por: Casacuberta-Partal, Miriam, et al.
Publicado: (2022) -
Improved diagnosis of active Schistosoma infection in travellers and migrants using the ultra-sensitive in-house lateral flow test for detection of circulating anodic antigen (CAA) in serum
por: van Grootveld, Rebecca, et al.
Publicado: (2018) -
Limited efficacy of repeated praziquantel treatment in Schistosoma mansoni infections as revealed by highly accurate diagnostics, PCR and UCP-LF CAA (RePST trial)
por: Hoekstra, Pytsje T., et al.
Publicado: (2022) -
Safety and infectivity of female cercariae in Schistosoma-naïve, healthy participants: a controlled human Schistosoma mansoni infection study
por: Koopman, Jan Pieter R., et al.
Publicado: (2023) -
Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST)
por: Hoekstra, Pytsje T., et al.
Publicado: (2020)